• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mechanism of abnormality in p27^<K1P1> expression in human lung cancer and its therapeutic application

Research Project

Project/Area Number 11670159
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionAichi Cancer Center Research Institute

Principal Investigator

MASUDA Akira  Aichi Cancer Center Research Institute, Division of Molecular Oncology, Senior Researcher, 分子腫瘍学部, 主任研究員 (50157202)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Takashi  Aichi Cancer Center Research Institute, Division of Molecular Oncology, Research Head, 分子腫瘍学部, 部長 (50231395)
HIDA Toyoaki  Aichi Cancer Center Research Institute, Research Institute, Researcher, 研究所, 研究員 (80250249)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2000: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1999: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsLung Cancer / p27^<K1P1> / Small Cell Lung Cancer / Cell Cycle / Apoptosis
Research Abstract

A previous study of ours unexpectedly found that in contrast to frequent reduction in non-small cell lung cancer (NSCLC) in association with poor prognosis, high expression of the p27^<K1P1> cyclin-dependent kinase (CDK) inhibitor was retained in virtually all small cell lung cancers (SCLCs), which represent the most aggressive form of lung cancer. This observation suggested the possibility that highly expressed p27^<K1P1> in SCLC may be non-functional, possibly due to multiple genetic defects in this tumor type. Biochemical analyses, however, revealed that p27^<K1P1> in SCLC is functional aas a CDK inhibitor, clearly showing induction apparently associated with G1/G0 arrest and efficient inhibition of cyclin-CDK kinase activities. Interestingly, we could show that induction of p27^<K1P1> confers on SCLC cells the ability to survive under culture conditions unfavorable for cell growth such as a lack of nutrients and hypoxia. Subsequent transfection experiments with p27^<K1P1> supported this notion. These obsevations suggest that high expression of p27^<K1P1> in vivo may favor the survival of SCLC by preventing apoptosis in a microenvironment unfavorable for cell proliferation.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Kozaki,K. et al.: "In vivo selected human lung cancer cell line H460-LNM35 consistently exhibits lymphogenous metastasis via both subcutaneous and orthotopic propagation."Cancer Res.. 69. 2535-2540 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yanagisawa,K. el al.: "Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers."Oncogene. 19. 2305-2311 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yatabe,Y. et al.: "Topographical distributions of allelic loss in individual non-small cell lung cancers."Am.J.Pathol.. 157. 985-993 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hida,T. et al.: "Cyclooxygenase (COX)-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines."Clin.Cancer Res.. 6. 2006-2011 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Haruki,N. et al.: "Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer."Cancer Res.. 60. 4689-4692 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masuda,A. et al.: "protective function of p27^<KIP1> again apoptosis in small cell lung cancer cells in unfavorable microenvironments."Am.J.Pathol.. 158. 87-96 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kozaki, K.et al.: "In vivo selected human lung cancer cell line H460-LNM35 consistently exhibits lymphogenous metastasis via both subcutaneous and orthotopic propagation."Cancer Res.. 69. 2535-2540 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yanagisawa, K.et al.: "Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers."Oncogene. 19. 2305-2311 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yatabe, Y.et al: "Topographical distributions of allelic loss in individual non-small cell lung cancers."Am. J.Pathol.. 157. 985-993 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hida, T.et al.: "Cyclooxygenase (COX)-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines."Clin. Cancer Res.. 6. 2006-2011 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Haruki, N.et al: "Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer."Cancer Res.. 60. 4689-4692 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masuda, A.et al: "Protective function of p27^<K1P1> against apoptosis in small cell lung cancer cells in unfavorable microenvironments."Am. J.Pathol.. 158. 87-96 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kozaki,K. et al.: "In vivo selected human lung cancer cell line H460-LNM35 consistently exhibits lymphogenous metastasis via both subcutaneous and orthotopic propagation."Cancer Res.. 69. 2535-2540 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yanagisawa,K. et al.: "Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers."Oncogene. 19. 2305-2311 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yatabe,Y. et al.: "Topographical distributions of allelic loss in individual non-small cell lung cancers."Am.J.Pathol.. 157. 985-993 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hida,T. et al.: "Cyclooxygenase (COX)-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines."Clin.Cancer Res.. 6. 2006-2011 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Haruki,N. et al.: "Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer."Cancer Res.. 60. 4689-4692 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Masuda,A. et al.: "Protective function of p27^<KIP1> against apoptosis in small cell lung cancer cells in unfavorable microenvironments."AM.J.Pathol.. 158. 87-96 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takahashi, T. et al.: "Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung"Oncogene. 18. 4295-4300 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Achiwa, H. et al.: "Prognostic significance of elevated cyclooxygenase 2 (COX-2) expression in primary resected lung adenocarcinomas"Clin. Cancer Res.. 5. 1001-1005 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Gotoh, K. et al.: "Somatic Frameshift Mutations in the TGF-β RII, IGF-IIR, BAX, hMSH3, and hMSH6 gene are uncommon in lung cancer"Carcinogenesis. 20. 499-502 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nomoto, S. et al.: "Cloning and characterization of the alternative promoter regions of the human LIMK2 gene responsible for alternative transcripts with tissue-specific expression"236. 259-271 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] "Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers"Oncogene. 18. 7180-7183 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kozaki, K. et al.: "In vivo selected human lung cancer cell line H460-LNM35 consistently exhibits lymphogenous metastasis via both subcutaneous and orthotopic propagation"Cancer Res.. (in press). (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi